Hematopoietic Stem Cells Transplantation Market Size

  • Report ID: 3937
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Hematopoietic Stem Cells Transplantation Market Size

Hematopoietic Stem Cells Transplantation Market size was over USD 3.05 billion in 2024 and is expected to exceed USD 10.16 billion by the end of 2037, growing at over 9.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hematopoietic stem cells transplantation is evaluated at USD 3.29 billion. The reason behind the growth is impelled by the rising prevalence of leukemia. Hematopoietic stem cell transplantation can be used to treat certain cancers, including leukemia, as stem cells aid in immune system restoration and the stimulation of new bone marrow development that may benefit patients to regenerate healthy bone marrow. In 2020, there were more than 474,510 new cases of leukemia reported globally.

The growing advancements in stem cell transplantation technology are believed to fuel the market growth. For instance, in February 2023, Lund University in Sweden discovered that stem cells have shown promise in treating the inflammation that underlies heart failure as it was found that patients receiving the treatment had more than 55% lower risk of heart attack or stroke, and the benefits rose to over 70% in patients with high inflammation since the treatment may decrease plaque instability.


Hematopoietic Stem Cells Transplantation Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3937
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hematopoietic stem cells transplantation is evaluated at USD 3.29 billion.

The hematopoietic stem cells transplantation market size was over USD 3.05 billion in 2024 and is expected to exceed USD 10.16 billion by the end of 2037, growing at over 9.7% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of leukemia and the growing advancements in stem cell transplantation technology will drive the market growth.

North America industry is likely to dominate majority revenue share 40% by 2037, impelled by presence of major key players in the region.

The major players in the market are Escape Therapeutics, Inc., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., CSG-BIO Company, Inc. (CellSave), CBR Systems, Inc., Pluristem Inc., Global Cord Blood Corporation, ViaCord, LLC, Cynata Therapeutics Limited, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample